i
Important informations
Instagram
Portal
Donate now

News and Events

LDI Research News

Read about the latest advances from the Lady Davis Institute for Medical Research (LDI) and its researchers, including new findings, grant awards, innovations, and collaborations. Please check this page regularly to keep up to date with the latest news at the LDI.

LDI Research News 1

Lady Davis Institute for Medical Research investigators awarded more than $12.9M from CIHR

Twelve research teams from the LDI were awarded $12,903,057 in combined funding through the Canadian Institutes of Health Research (CIHR) Fall 2025 Project Grant and Team Grants: Bringing Biology to Cancer Prevention competitions.
Read more
Dr. Mark Basik

Cutting-edge study highlights the role of a new blood test that may help decide who needs chemotherapy in patients with aggressive breast cancer

The research provides new insights into the prognostic value of ctDNA and its ability to guide personalized treatment strategies for patients with triple-negative breast cancer.
Read more
LDI logo

New study links GLP-1 receptor agonists to increased risk of gastroesophageal reflux disease (GERD) in type 2 diabetes patients

The study shows that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which include Ozempic®, Rybelsus® and other widely- prescribed drugs for type 2 diabetes and obesity management, may increase the risk of developing gastroesophageal reflux disease (GERD) and its complications compared to sodium–glucose cotransporter-2 (SGLT-2) inhibitors (such as Brenzavvy™, Invokana®, etc.).
Read more
LDI logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.